TABLE 1.
Demographics of patients treated for VIM-Pseudomonas (PsA) infections
| Demographics, N = 21 patients | |
|---|---|
| Male, n (%) | 16 (76.2) |
| Median age, years (IQR)e | 52 (40–58) |
| Comorbidities on admission, n (%) | |
| Hypertension | 8 (38.1) |
| Diabetes | 5 (23.8) |
| Congestive heart failure | 6 (28.6) |
| Chronic respiratory failure | 5 (23.8) |
| Cardiac arrest | 6 (28.6) |
| Renal failure | 9 (42.9) |
| Solid organ transplant | 4 (19.0) |
| Coronary artery disease | 4 (19.0) |
| Anoxic/traumatic brain injury | 5 (23.8) |
| Cerebrovascular accident | 2 (9.5) |
| COVID-19 coinfection | 4 (19.0) |
| Chronic obstructive pulmonary disease | 3 (14.3) |
| Renal replacement therapy at time of culture collection, n (%) | 10 (47.6) |
| Mechanical ventilation at time of index culture, n (%) | 15 (71.4) |
| Tracheostomy at time of index culture, n (%) | 10 (47.6) |
| PEG tube at time of index culture, n (%) | 3 (14.3) |
| ICU for at least 24 hr, n (%) | 13 (61.9) |
| Medical | 4 (19.0) |
| Surgical | 6 (28.6) |
| Trauma | 3 (14.3) |
| Median total length of stay, days (IQR)a | 77 (46–237) |
| Median length of stay to positive culture, days (IQR) | 30 (17–51) |
| Onset of colonization and/or infection | |
| Hospital onsetb | 19 (90.4) |
| Communityc | 1 (4.8) |
| Hospital onset; OSHd | 1 (4.8) |
| Colonized prior to infection, n (%) | 0 (0) |
| Colonized after infection, n (%) | 8 (38.1) |
| Disposition at 30 days from index culture, n (%) | |
| Expired | 6 (28.6) |
| Hospitalized | 8 (38.1) |
| Home | 2 (9.5) |
| Long-term care center | 4 (19.0) |
| Skilled nursing facility | 1 (4.8) |
a
Includes two different encounters for two patients who were re-admitted and re-infected with VIM-PsA.
b
VIM isolates found >3 days of hospitalization.
c
VIM isolates found <3 days of hospitalization.
d
Sample taken after patient transferred from OSH (outside hospital).
e
IQR, interquartile range.